GAUDIO, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 3.847
EU - Europa 2.032
AS - Asia 1.350
AF - Africa 267
SA - Sud America 167
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 1
Totale 7.673
Nazione #
US - Stati Uniti d'America 3.689
SG - Singapore 777
IT - Italia 557
IE - Irlanda 553
UA - Ucraina 490
CN - Cina 479
CI - Costa d'Avorio 209
BR - Brasile 157
CA - Canada 155
RU - Federazione Russa 133
SE - Svezia 76
DE - Germania 61
FR - Francia 52
IN - India 33
SN - Senegal 33
CH - Svizzera 20
GB - Regno Unito 19
NG - Nigeria 16
UZ - Uzbekistan 13
GR - Grecia 12
NL - Olanda 12
FI - Finlandia 11
VN - Vietnam 11
EU - Europa 8
HK - Hong Kong 8
AT - Austria 7
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
IQ - Iraq 5
PL - Polonia 5
BG - Bulgaria 4
LB - Libano 4
RS - Serbia 4
AR - Argentina 3
PY - Paraguay 3
TR - Turchia 3
ZA - Sudafrica 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
HR - Croazia 2
JP - Giappone 2
KZ - Kazakistan 2
MA - Marocco 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
DZ - Algeria 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
LK - Sri Lanka 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.673
Città #
Santa Clara 827
Dublin 553
Chandler 512
Singapore 421
Jacksonville 406
Boardman 245
Abidjan 209
Chicago 188
Cambridge 154
Lawrence 154
Andover 147
Nanjing 144
Catania 120
Toronto 109
Ashburn 82
Des Moines 74
Wilmington 74
San Mateo 62
Ottawa 46
Saint Petersburg 40
Civitanova Marche 36
Nanchang 36
Shenyang 36
Hebei 35
Dakar 33
Jiaxing 31
Bremen 27
Palermo 24
Changsha 21
Milan 21
Beijing 20
Tianjin 19
Abuja 16
Padova 16
Seattle 16
Rome 15
Modica 14
Hangzhou 13
Pune 13
Civitavecchia 11
Houston 11
Nocera Inferiore 11
Norwalk 11
Washington 11
Falls Church 10
Moscow 10
Munich 10
Mascalucia 9
Messina 9
Ann Arbor 8
Council Bluffs 8
Dong Ket 8
Lappeenranta 8
Redwood City 8
Los Angeles 7
São Paulo 7
Caltanissetta 6
Ningbo 6
Budapest 5
Casalecchio di Reno 5
Frankfurt Am Main 5
Giarre 5
Jinan 5
Lausanne 5
Redmond 5
Taizhou 5
Zhengzhou 5
Brasília 4
Campinas 4
Cesa 4
Changchun 4
Cologne 4
Den Haag 4
Fairfield 4
Hong Kong 4
Osasco 4
Phoenix 4
Rio de Janeiro 4
Salvador 4
Trecastagni 4
Avola 3
Coralville 3
Fiumefreddo Di Sicilia 3
Groningen 3
Guangzhou 3
Hanoi 3
Helsinki 3
Lanzhou 3
Naples 3
Pozzo Di Gotto 3
Ragusa 3
Riposto 3
Shanghai 3
Sortino 3
Teresópolis 3
Trento 3
Urbino 3
Ali Terme 2
Anápolis 2
Baghdad 2
Totale 5.332
Nome #
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 104
A rare cause of leg pain 92
Venous thromboembolism in hospital emergency room. A retrospective study on climatic effect 81
Dehydroepiandrosterone (DHEA) replacement therapy in elderly men with osteoporosis 80
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 78
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 78
A systematic review of arterial stiffness, wave reflection and air pollution 77
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 76
Augmentation index is increased in patients with inflammatory bowel disease, a meta-analysis 75
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 73
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 73
Anticoagulants and osteoporosis 73
Deep vein thrombosis related to environment (Review) 72
Correlation between family history of hypertension and haemostatic disorders 70
Melorheostosis and Osteopoikilosis Clinical and Molecular Description of an Italian Case Series 69
Effetti del raloxifene sulla densità del parenchima mammario 68
Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers 67
Platelet-Derived Microparticles (MPs) and Thrombin Generation Velocity in Deep Vein Thrombosis (DVT): Results of a Case–Control Study 67
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 66
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a 2-years randomized, double-blind, placebo-controlled study 66
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 66
Vascular dysfunction in Cardiorenal Syndrome type 4 66
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 65
Donne in post-menopausa in trattamento farmacologico per la prevenzione primaria delle fratture osteoporotiche: primi dati di uno studio pilota su aderenza e persistenza alla terapia 65
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? 65
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 64
Review: UPDATE sul metabolismo del magnesio 64
Raloxifene e rischio cardiovascolare 64
Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease 63
Bisphosphonates in the treatment of thalassemia-associated osteoporosis 62
A suspicious fracture 62
Vitamin D levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients 62
Paget's bone disease is not always the culprit 61
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 61
Paget's Disease of Bone and Cardiovascular Risk: a Pilot Study 61
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 60
Apparato locomotore 60
Il neridronato previene il bone loss durante la terapia antiandrogena per il cancro prostatico 60
Alterazioni emostatiche in pazienti con arteriopatia obliterante periferica con e senza diabete 60
More is not better 60
Heredity of the haemostatic disorders in non insulin dependent diabetes (NIDDM) 59
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 59
Osteoporosis and beta-thalassemia major: Role of the IGF-I/IGFBP-III axis 58
Biphosphonates prevent bone loss in thalassemia major patients 58
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience 58
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 57
A strange case of dyspnoea 57
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 56
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 56
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 56
The relationship between inhibitors of the Wnt signaling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus 56
I bifosfonati prevengono la perdita d'osso nei pazienti thalassemici 56
Vascular dysfunction of COVID-19 is partially reverted in the long-term 56
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis 55
When the FRAX® test is applied to controlled clinical trials 55
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 55
Osteoprotegerina ed osteoporosi nei thalassemici 55
Effetti della somministrazione di EPO sul metabolismo osseo nel ratto 55
Peripheral artery disease and osteoporosis: Not only age-related (Review) 55
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate 54
Ridotta risposta terapeutica all' alendronato in pazienti depresse affette da osteoporosi 54
Raloxifene and pituitary secretion in post-menopausal women 54
Cortisol Secretion, Sensitivity, and Activity Are Associated With Hypertension in Postmenopausal Eucortisolemic Women 54
Bone islands. 54
Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism 54
Successful neridronate therapy in pregnancy-associated osteoporosis 53
Hemostatic effects of diets containing olive or soy oil in hypertensive patients 53
Livelli sierici di osteoprotegerina e markers del turnover osseo durante il trattamento con raloxifene: dati preliminari 53
Hemostatic changes in vasculitides 52
Riduzione della densità minerale volumetrica in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 52
Effetti del raloxifene sulla secrezione ipofisaria 52
Response to Letter to the Editor: "Methodological Issues Regarding Cortisol Secretion, Sensitivity, and Activity are Associated With Hypertension in Postmenopausal Eucortisolemic Women" 52
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 52
It Is Time for a Routine Measurement of Aortic Stiffness in Inflammatory Bowel Disease 51
Effects of administration of Dehydroepiandrosterone (DHEA) on male senile osteoporosis 51
Insights from experiences on antiplatelet drugs in stroke prevention: A review 51
Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and causal associations in transversal studies: The time-series analysis to reveal potential confounders. comment on “gaudio et al. vitamin d levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients. Int. j. environ. res. public health 2021, 18, 3491” 51
Livelli circolanti di citochine osteotrope e rimodellamento osseo nei pazienti thalassemici 50
Effects of agonistic physical activity on the activation of WNT/beta-catenin signaling 50
Effetti del Raloxifene sulla secrezione ipofisaria in post-menopausa 49
Ultrasonografia ossea e DEXA nella valutazione dell' osteoporosi secondaria ad insufficienza renale cronica in trattamento sostitutivo emodialitico 49
What changed in the Italian internal medicine and geriatric wards during the lockdown 49
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 49
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 48
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 48
Role of genetic pattern on bone mineral density in thalassemic patients 48
Eritropoietina: un nuovo D.A.B.A.? 47
Erythropoietin: A novel DABA? 47
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 47
Effetti del fitoestrogeno genisteina sul metabolismo osseo in donne in postmenopausa:COFIN 2002 dati a 12 mesi 47
Neridronate in the treatment of thalassemia-induced osteoporosis 46
Neridronate in the treatment of thalassemia-induced osteoporosis 46
Relationships between osteoprotegerin, receptor activator of the nuclear factor kB ligand and serum levels and carotid intima-media thickness in patients with type 2 diabetes mellitus. 45
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 45
Hematological Diseases and Osteoporosis 45
Somministrazione settimanale e giornaliera di alendronato nel trattamento dell'osteoporosi della Thalassemia Major 44
Handgrip strength to discriminate high fracture risk in type 2 diabetes mellitus patients. 44
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle 43
Rete Osteoporosi Sicilia (Sicilian Osteoporosis Network): an IT platform for the improvement of diagnosis and treatment of osteoporosis in Sicily. 43
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 43
Totale 5.847
Categoria #
all - tutte 31.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020146 0 0 0 0 0 0 0 0 0 0 105 41
2020/2021892 33 82 90 22 245 38 100 8 74 49 104 47
2021/20221.117 112 156 14 20 184 15 162 43 102 2 59 248
2022/20231.705 164 66 22 143 189 308 7 261 418 27 46 54
2023/2024802 38 141 49 38 38 177 6 55 2 30 130 98
2024/20252.428 18 428 151 96 673 380 55 124 156 346 1 0
Totale 8.012